
Ask a doctor about a prescription for AMLODIPINE AUROVITAS 5 mg TABLETS
Package Leaflet: Information for the User
Amlodipine Aurovitas 5 mg Tablets EFG
Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.
Contents of the Package Leaflet
Amlodipine Aurovitas contains the active substance amlodipine, which belongs to a group of medicines known as calcium antagonists.
Amlodipine Aurovitas is used to treat high blood pressure (hypertension) or a certain type of chest pain called angina, which includes a rare type called Prinzmetal's or variant angina.
In patients with high blood pressure, this medicine works by relaxing blood vessels, so that blood passes through them more easily. In patients with angina, amlodipine improves blood supply to the heart muscle, which receives more oxygen and as a result, chest pain is prevented. This medicine does not provide immediate relief of chest pain due to angina.
Do not take Amlodipine Aurovitas
Warnings and precautions
Consult your doctor or pharmacist before starting to take amlodipine.
You should inform your doctor if you have or have had any of the following diseases:
Children and adolescents
Amlodipine has not been studied in children under 6 years of age. Amlodipine should only be used to treat high blood pressure in children and adolescents from 6 to 17 years of age (see section 3). For more information, consult your doctor.
Other medicines and Amlodipine Aurovitas
Tell your doctor or pharmacist if you are taking, have recently taken, or might take any other medicines, including those obtained without a prescription.
Amlodipine Aurovitas may affect or be affected by other medicines, such as:
If you are already taking other medicines to treat high blood pressure, amlodipine may lower your blood pressure even further.
Taking Amlodipine Aurovitas with food and drinks
People taking amlodipine should not consume grapefruit or grapefruit juice. This is because grapefruit and grapefruit juice can lead to an increase in blood levels of the active ingredient amlodipine, which can cause an unpredictable increase in the blood pressure-lowering effect of amlodipine.
Pregnancy and breastfeeding
Pregnancy
The safety of amlodipine during pregnancy has not been established. If you are pregnant or breastfeeding, think you may be pregnant, or plan to become pregnant, consult your doctor before using this medicine.
Breastfeeding
Amlodipine has been shown to pass into breast milk in small amounts. If you are breastfeeding or plan to start breastfeeding, inform your doctor before taking amlodipine.
Consult your doctor or pharmacist before taking any medicine.
Driving and using machines
Amlodipine may affect your ability to drive or use machines. If the tablets make you feel sick, dizzy, or tired, or cause you headaches, do not drive or use machinery and consult your doctor immediately.
Amlodipine Aurovitas contains sodium
This medicine contains less than 23 mg of sodium (1mmol) per tablet; this is, essentially "sodium-free".
Follow exactly the administration instructions of this medicine indicated by your doctor or pharmacist. In case of doubt, consult your doctor or pharmacist again.
The recommended initial dose is 5 mg of amlodipine, once a day. The dose can be increased to 10 mg of amlodipine, once a day.
You can take this medicine before or after meals. It should be taken at the same time each day, with a glass of water. Do not take amlodipine with grapefruit juice.
Use in children and adolescents
For children and adolescents (between 6-17 years of age), the recommended initial dose is normally 2.5 mg per day. The maximum recommended dose is 5 mg per day. Currently, amlodipine 2.5 mg is not available, and a dose of 2.5 mg cannot be obtained with Amlodipine Aurovitas 5 mg tablets, as these tablets are not manufactured to be divided into equal parts.
It is important not to interrupt the administration of the tablets. Do not wait until the tablets are finished to go to your doctor.
If you take more Amlodipine Aurovitas than you should
Taking too many tablets can cause a drop in blood pressure or even a dangerous drop. You may feel dizzy, faint, or weak. If the drop in blood pressure is severe, it can cause shock. You may feel your skin cold and wet, and you could lose consciousness.
Excess fluid can accumulate in the lungs (pulmonary edema) causing difficulty breathing, which can develop up to 24-48 hours after ingestion.
In case of overdose or accidental ingestion, consult your doctor immediately or call the Toxicology Information Service, phone: 91 562 04 20, indicating the medicine and the amount ingested.
If you forget to take Amlodipine Aurovitas
Do not worry. If you forget to take a tablet, do not take that dose. Take the next dose at the correct time. Do not take a double dose to make up for forgotten doses.
If you stop taking Amlodipine Aurovitas
Your doctor will indicate how long you should be taking this medicine. Your disease may recur if you stop taking this medicine before your doctor tells you to.
If you have any other questions about the use of this medicine, ask your doctor or pharmacist.
Like all medicines, this medicine can cause side effects, although not everybody gets them.
Go to your doctor immediatelyif you experience any of the following side effects after taking this medicine.
The following side effect has been reported very frequently. If this causes problems or lasts more than a week, consult your doctor.
Very common: may affect more than 1 in 10 people
The following side effects have been reported frequently.If any of these cause problems or last more than a week, consult your doctor.
Common: may affect up to 1 in 10 people
Other side effects have been reported, which are included in the following list. If you think any of the side effects you are suffering from is serious, or if you notice any side effects not mentioned in this leaflet, inform your doctor or pharmacist.
Uncommon: may affect up to 1 in 100 people
Rare: may affect up to 1 in 1,000 people
Very rare: may affect up to 1 in 10,000 people
Frequency not known (cannot be estimated from available data):tremors, postural rigidity, mask-like face, slow and unsteady gait.
Reporting of side effects
If you experience any side effects, consult your doctor or pharmacist, even if it is possible side effects not listed in this leaflet. You can also report side effects directly through the Spanish Pharmacovigilance System for Human Use Medicines: https://www.notificaram.es. By reporting side effects, you can help provide more information on the safety of this medicine.
Keep this medicine out of the sight and reach of children.
This medicine does not require special storage conditions.
Do not use this medicine after the expiry date stated on the carton after EXP. The expiry date is the last day of the month indicated.
Medicines should not be disposed of via wastewater or household waste. Place the packaging and any unused medicine in the SIGRE collection point at the pharmacy. If in doubt, ask your pharmacist how to dispose of the packaging and any unused medicine. This will help protect the environment.
Composition of Amlodipine Aurovitas
Appearance of the product and contents of the pack
White to off-white, flat, beveled-edge, cylindrical tablets, marked with the letter "C" on one face and "58" on the other. The size is 7.9 mm x 5.6 mm.
Amlodipine Aurovitas 5 mg tablets EFG are available in PVC/PVdC-Aluminum blisters.
Pack sizes:
Blisters: 20, 28, 30, 56, 60, 98, and 100 tablets.
Not all pack sizes may be marketed.
Marketing authorization holder and manufacturer
Marketing authorization holder:
Aurovitas Spain, S.A.U.
Avda. de Burgos, 16-D
28036 Madrid
Spain
Manufacturer:
APL Swift Services (Malta) Limited
HF26, Hal Far Industrial Estate, Hal Far
Birzebbugia, BBG 3000
Malta
This medicine is authorized in the Member States of the European Economic Area under the following names:
Belgium: Amlodipin AB 5 mg tablets
Spain: Amlodipine Aurovitas 5 mg tablets EFG
Poland: ApoAmlo
Portugal: Amlodipina Aurovitas
Czech Republic: Amlodipin Aurovitas 5 mg tablets
Date of last revision of this leaflet:January 2023
Detailed information on this medicine is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) (http://www.aemps.gob.es)
The average price of AMLODIPINE AUROVITAS 5 mg TABLETS in November, 2025 is around 1.25 EUR. Prices may vary depending on the region, pharmacy, and whether a prescription is required. Always check with a local pharmacy or online source for the most accurate information.
The best alternatives with the same active ingredient and therapeutic effect.
Discuss dosage, side effects, interactions, contraindications, and prescription renewal for AMLODIPINE AUROVITAS 5 mg TABLETS – subject to medical assessment and local rules.